Acute and chronic behavioural sequelae resulting from intrastriatal injection of an NMDA agonist
- 30 June 1994
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 48 (2) , 441-446
- https://doi.org/10.1016/0091-3057(94)90550-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the ratBrain Research, 1992
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991
- Excitotoxic injury of the neostriatum: a model for Huntington's diseaseTrends in Neurosciences, 1990
- Abnormalities of Striatal Projection Neurons andN-Methyl-D-Aspartate Receptors in Presymptomatic Huntington's DiseaseNew England Journal of Medicine, 1990
- Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatumNeuroscience, 1988
- Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis StudyJournal of Neurochemistry, 1988
- In vivo presynaptic control of dopamine release in the cat caudate nucleus—II. Facilitatory or inhibitory influence ofl-glutamateNeuroscience, 1986
- A reliable, rapid and inexpensive method for producing and implanting chronic cannulae into brains of small animalsPharmacology Biochemistry and Behavior, 1986
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Lesion of striatal neurons with kainic acid provides a model for Huntington's choreaNature, 1976